Xylem Inc
NYSE:XYL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Xylem Inc
NYSE:XYL
|
US |
|
Mitsubishi UFJ Financial Group Inc
TSE:8306
|
JP |
|
Oji Holdings Corp
TSE:3861
|
JP |
|
Puradelta Lestari Tbk PT
IDX:DMAS
|
ID |
|
A
|
Asahi Intecc Co Ltd
TSE:7747
|
JP |
|
Vestas Wind Systems A/S
CSE:VWS
|
DK |
|
Doosan Enerbility Co Ltd
KRX:034020
|
KR |
|
Hermes International SCA
PAR:RMS
|
FR |
|
OFS Capital Corp
NASDAQ:OFS
|
US |
|
Indaptus Therapeutics Inc
NASDAQ:INDP
|
US |
|
Bank Jago Tbk PT
IDX:ARTO
|
ID |
|
Lintec Corp
TSE:7966
|
JP |
|
Harvard Bioscience Inc
NASDAQ:HBIO
|
US |
Wall St Price Targets
XYL Price Targets Summary
Xylem Inc
According to Wall Street analysts, the average 1-year price target for XYL is 152.21 USD with a low forecast of 125.24 USD and a high forecast of 176.4 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is XYL's stock price target?
Price Target
152.21
USD
According to Wall Street analysts, the average 1-year price target for XYL is 152.21 USD with a low forecast of 125.24 USD and a high forecast of 176.4 USD.
What is the Revenue forecast for Xylem Inc?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 5%.
What is the Operating Income forecast for Xylem Inc?
Projected CAGR
9%
Over the last 13 years, the compound annual growth rate for Operating Income has been 8%. The projected CAGR for the next 8 years is 9%.
What is the Net Income forecast for Xylem Inc?
Projected CAGR
16%
Over the last 13 years, the compound annual growth rate for Net Income has been 9%. The projected CAGR for the next 5 years is 16%.
